Small Pharma Announces Completion of SPL026 Phase IIa Trial and Secures...

Psychedelics Weekly – Prop 122 and Data Privacy, Ending the Crack/Cocaine...

Israel- Based Clearmind Medicine Granted U.S. Patent for Psychedelic-Based Alcohol Substitute

Numinus to Participate in the KCSA Mental Health Virtual Investor Conference...

Thinking Beyond Set and Setting in the Psychedelic Experience

Psyence and Filament Health Announce Worldwide Licensing Agreement of Psilocybin Capsule...

Wesana Health Announces Receipt of Short-Term Loan

PT378 – Course Corrections, Preparation, and High-dose Experiences: “Who Are You...

Psychedelic Bulletin #127: Psilocybin Shows Promise in Bipolar Disorder; Gilgamesh Raises...

Gilgamesh Pharmaceuticals Raises $39 Million Series B to Advance Mental Health...

Load more